Pharmaceutical Companies

Pharmaceutical Companies need to monitor trial results in real time at all participating sites to take earlier “Go” or “No Go” decisions.
- LMS provides centralized data management with unique multi-site integration capabilities to store all lesion measures and make them available at all times.
- Lesion measures stored in the centralized data management system can then be correlated with other functional or anatomical information.
Regulatory authorities require pharmaceutical companies to conform to international criteria such as RECIST to evaluate drug effectiveness.
- LMS automatically generates reports according to RECIST criteria.
- LMS provides automatic and consistent quantification of lesion growth to limit discordance.
Lesion volume and attenuation changes bring additional value to assess molecule behavior and drug effectiveness.
- LMS provides volume growth and attenuation values and histogram.
- Volume and attenuation values and changes are stored in the centralized data management system along with diameter information.










LMS increases the diagnosis and follow-up quality, which is good for the radiologists and of course patients, and the oncologists love the automatic report that is generated...